Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy

PURPOSE: Biomarkers are needed to guide treatment decisions in recurrent ovarian cancer, as a high proportion of patients do not benefit from treatments. Data on immune subsets in patients receiving chemotherapy are scarce. We investigated the impact of T cells, B cells, neutrophils and the neutroph...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Ovarian Res
Egile Nagusiak: Henriksen, Jon Røikjær, Nederby, Line, Donskov, Frede, Waldstrøm, Marianne, Adimi, Parvin, Jakobsen, Anders, Steffensen, Karina Dahl
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7229632/
https://ncbi.nlm.nih.gov/pubmed/32414391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-020-00661-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak